BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38130311)

  • 1. Low
    Xie Z; Chen N
    Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Chen N
    Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
    Zhao YW; Ma W; Jiang F; Xie Y; Tang L
    Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of
    Liu W; Xiao Z; Dong M; Li X; Huang Z
    Oncol Lett; 2024 Mar; 27(3):97. PubMed ID: 38288038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
    Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
    Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
    Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH
    Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
    Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
    Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.
    Qiu J; Wang Z; Zhao L; Zhang P; Xu Y; Xia Q
    Front Mol Biosci; 2023; 10():1201155. PubMed ID: 37529377
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.
    Zhang J; Zhao Q; Huang H; Lin X
    BMC Urol; 2024 Jan; 24(1):26. PubMed ID: 38297313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognosis analysis of PAQR5 in kidney cancer.
    Lu T; Xu HR; Dong W; Dong H
    Front Oncol; 2022; 12():955510. PubMed ID: 36119517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 17. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
    Tang YF; Qiao B; Huang YB; Wang M
    Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
    Sun X; Liu P
    Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
    Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.